T lymphocyte activation pathway

The **T lymphocyte activation pathway** refers to the complex sequence of molecular and cellular events that lead to the functional activation of T cells—a central component in adaptive immunity. Activation begins when a naïve or memory T cell recognizes an antigen presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells via its unique T cell receptor. This recognition provides signal 1. A second costimulatory signal is required for full activation; this is typically delivered through interactions between costimulatory molecules such as CD28 on the T cell and B7 proteins on APCs. Upon receiving both signals, intracellular signaling cascades involving kinases and adaptor proteins are triggered—these include phosphorylation events mediated by Lck and ZAP70, recruitment and phosphorylation of LAT and SLP76, generation of second messengers like diacylglycerol and IP3 via PLCγ activity, calcium influx through CRAC channels leading to calcineurin/NFAT-mediated gene transcription, PKCθ-mediated NFκB/AP1 transcriptional activity—all culminating in cytokine production such as IL2 that drives proliferation and differentiation into effector subsets. Activated helper CD4+ cells can differentiate into Th1/Th2/Th17/Treg lineages depending on cytokine milieu; cytotoxic CD8+ cells acquire direct killing capacity against infected or malignant targets[1][3][4][5]. Dysregulation at any step can result in immunodeficiency or autoimmunity. The overall process is not itself a druggable "target," but many individual proteins within it—including receptors like PD1/CTLA4/CD28/CD3—are established therapeutic targets for immunomodulatory drugs used especially in cancer immunotherapy[2][3]. Because "T lymphocyte activation pathway" describes a broad biological process rather than a discrete molecule/receptor/protein family member suitable for direct pharmacological targeting or biomarker development—and because it encompasses numerous distinct molecular entities—it should not be considered a canonical therapeutic target per se. > “Understanding these steps in T cell activation not only provides insights into fundamental workings... but also highlights potential targets for therapeutic interventions... Scientists have developed therapies to enhance immune system’s ability... by manipulating T cell responses.” [3]

Other names

T cell activation pathwayT lymphocyte signaling pathwayT cell signaling cascade